Qiming Venture Partners

Qiming Venture Partners is a prominent venture capital firm established in 2006 and headquartered in Shanghai, with additional offices in Beijing, Suzhou, and Hong Kong. The firm specializes in investing in early to growth-stage companies across various sectors, including media and internet, information technology, consumer and retail, healthcare, and clean technology in China. Since its inception, Qiming has built a reputation as a leading investment firm in the region, managing multiple funds with over $1 billion in assets. The firm aims to support promising entrepreneurs and innovative businesses, contributing to the development of China's dynamic economic landscape.

Sam Chen

Associate

Nan Chen

Principal

Anna French

Partner

Jinda Gao

Executive Director

William Hu

Managing Partner

Duane Kuang

Co-Founder & Managing Partner

Grace Lee

Partner

Nisa Leung

Managing Partner

Shuo Mao

vice_president

Mark McDade

Partner

Gary Rieschel

Co-Founder & Managing Partner

Amy Tang

Venture Partner

Shiyu Wang

Partner

Bonnie Wang

Principal

Jing Wu

Partner

Kuantai Yeh

Partner

Janet Yu Ph.D

Partner

Alex Zhou

Partner

Past deals in Medical

CureGenetics

Series B in 2022
CureGenetics is a healthcare company focused on the research and development of gene editing technologies and molecular diagnostics. It specializes in creating innovative medicines aimed at providing advanced treatments for cancers and genetic diseases. By developing a gene editing solution and a delivery platform, CureGenetics aims to enhance therapeutic options and improve patient outcomes in the field of genetic medicine.

Hope Medicine

Series B in 2021
Hope Medicine focuses on researching, developing, and commercializing innovative biopharmaceuticals aimed at enhancing the quality of life for patients with various prevalent diseases. The company specializes in translational medicine, utilizing insights from global research initiatives to create monoclonal antibodies, protein drugs, and other therapeutic options targeting endocrine, cardiovascular, and metabolic disorders. By addressing the needs of underserved patient populations, Hope Medicine strives to improve health outcomes and provide access to effective and affordable treatments.

Just Medical

Series B in 2021
Just Medical is an artificial orthopedic implant device and system developer.

SinoUnited Health

Series C in 2021
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopaedics, and neurology services. Established in 2004, the center offers a comprehensive range of treatments, including services for foot and ankle issues, acupuncture, chronic pain management, movement disorders, migraines, tremors, electromyography, balance training, and post-stroke care. The facility is designed to provide a comfortable environment that meets international standards, ensuring a high-quality experience for patients. SinoUnited Health has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, reinforcing its commitment to enhancing patient satisfaction and well-being within the community.

Newsoara

Venture Round in 2021
Newsoara is a biomedical technology developer that specializes in the development of medical devices.

Delta Medical

Series E in 2021
Beijing Delta Medical Co., Ltd. designs and manufactures sports medicine surgical instruments, intraoperative consumables and rehabilitation products. It offer products, such as shoulder arthroscopic instrument, PEEK suture anchor, titanium suture anchor, anterior cruciate ligament and posterior cruciate ligament reconstruction instrument, PEEK interference screw, titanium interference screw, ultra high speed fiber, ultra high speed fiber tape, needle loop, shaver system, arthroscopic hand instrument, medical face shield, and medical eye shield. It also provides sports rehabilitation services. The company is based in Beijing, China.

dMed

Series C in 2020
dMed Company Limited, also known as, dMed Biopharmaceutical Co., Ltd. operates as clinical contract research organization providing services for development of medicines and medical devices. The company offer services, including consulting, clinical operations, biostatistics & programming, data management, pharmacovigilance, clinical science & medical affairs, quality assurance, and regulatory affairs & Strategy. It serves biopharmaceutical and medical device companies. dMed Company Limited was founded in 2016 and is based in Shanghai, China.

Delta Medical

Series D in 2020
Beijing Delta Medical Co., Ltd. designs and manufactures sports medicine surgical instruments, intraoperative consumables and rehabilitation products. It offer products, such as shoulder arthroscopic instrument, PEEK suture anchor, titanium suture anchor, anterior cruciate ligament and posterior cruciate ligament reconstruction instrument, PEEK interference screw, titanium interference screw, ultra high speed fiber, ultra high speed fiber tape, needle loop, shaver system, arthroscopic hand instrument, medical face shield, and medical eye shield. It also provides sports rehabilitation services. The company is based in Beijing, China.

Belief Biomed

Debt Financing in 2020
Belief Biomed brings the latest research achievements in precision medicine in Triangle area into production and promotes international collaboration by connecting established investors from China to explore the vast opportunity of North Carolina.

CureGenetics

Series A in 2020
CureGenetics is a healthcare company focused on the research and development of gene editing technologies and molecular diagnostics. It specializes in creating innovative medicines aimed at providing advanced treatments for cancers and genetic diseases. By developing a gene editing solution and a delivery platform, CureGenetics aims to enhance therapeutic options and improve patient outcomes in the field of genetic medicine.

Newsoara

Series B in 2019
Newsoara is a biomedical technology developer that specializes in the development of medical devices.

SinoUnited Health

Series C in 2019
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopaedics, and neurology services. Established in 2004, the center offers a comprehensive range of treatments, including services for foot and ankle issues, acupuncture, chronic pain management, movement disorders, migraines, tremors, electromyography, balance training, and post-stroke care. The facility is designed to provide a comfortable environment that meets international standards, ensuring a high-quality experience for patients. SinoUnited Health has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, reinforcing its commitment to enhancing patient satisfaction and well-being within the community.

Vongi

Series B in 2019
Vongi is a clinical medicine-based chronic disease patient management platform.

dMed

Series B in 2019
dMed Company Limited, also known as, dMed Biopharmaceutical Co., Ltd. operates as clinical contract research organization providing services for development of medicines and medical devices. The company offer services, including consulting, clinical operations, biostatistics & programming, data management, pharmacovigilance, clinical science & medical affairs, quality assurance, and regulatory affairs & Strategy. It serves biopharmaceutical and medical device companies. dMed Company Limited was founded in 2016 and is based in Shanghai, China.

Delta Medical

Series C in 2019
Beijing Delta Medical Co., Ltd. designs and manufactures sports medicine surgical instruments, intraoperative consumables and rehabilitation products. It offer products, such as shoulder arthroscopic instrument, PEEK suture anchor, titanium suture anchor, anterior cruciate ligament and posterior cruciate ligament reconstruction instrument, PEEK interference screw, titanium interference screw, ultra high speed fiber, ultra high speed fiber tape, needle loop, shaver system, arthroscopic hand instrument, medical face shield, and medical eye shield. It also provides sports rehabilitation services. The company is based in Beijing, China.

Bondent Technology

Series D in 2019
Provider of integrated oral medical solutions for oral health and dental industry. The company offers technical training, operation and management consulting services to their clients. The company also involves in the design, development, manufacturing, and sales of oral medical equipment, providing a full fledged ecosystem for the dental and oral health industry.

ZD Medical

Series A in 2019
ZD Medical is a medical device company manufacturing optical coherence tomography angiography devices.

SinoUnited Health

Series B in 2019
SinoUnited Health is a medical center based in Shanghai, China, specializing in sports medicine, physical therapy, pain management, orthopaedics, and neurology services. Established in 2004, the center offers a comprehensive range of treatments, including services for foot and ankle issues, acupuncture, chronic pain management, movement disorders, migraines, tremors, electromyography, balance training, and post-stroke care. The facility is designed to provide a comfortable environment that meets international standards, ensuring a high-quality experience for patients. SinoUnited Health has built a strong reputation for delivering reliable diagnoses and effective treatment outcomes, reinforcing its commitment to enhancing patient satisfaction and well-being within the community.

Anxin Doctor

Series B in 2019
Anxin Doctor is a mobile maternal and pediatric health platform that connects patients with obstetrics, gynecology doctors and pediatrics doctors.

CureGenetics

Series A in 2018
CureGenetics is a healthcare company focused on the research and development of gene editing technologies and molecular diagnostics. It specializes in creating innovative medicines aimed at providing advanced treatments for cancers and genetic diseases. By developing a gene editing solution and a delivery platform, CureGenetics aims to enhance therapeutic options and improve patient outcomes in the field of genetic medicine.

dMed

Series B in 2018
dMed Company Limited, also known as, dMed Biopharmaceutical Co., Ltd. operates as clinical contract research organization providing services for development of medicines and medical devices. The company offer services, including consulting, clinical operations, biostatistics & programming, data management, pharmacovigilance, clinical science & medical affairs, quality assurance, and regulatory affairs & Strategy. It serves biopharmaceutical and medical device companies. dMed Company Limited was founded in 2016 and is based in Shanghai, China.

Bondent Technology

Series C in 2018
Provider of integrated oral medical solutions for oral health and dental industry. The company offers technical training, operation and management consulting services to their clients. The company also involves in the design, development, manufacturing, and sales of oral medical equipment, providing a full fledged ecosystem for the dental and oral health industry.

ZD Medical

Series A in 2018
ZD Medical is a medical device company manufacturing optical coherence tomography angiography devices.

Vongi

Series A in 2017
Vongi is a clinical medicine-based chronic disease patient management platform.
Qiang Sen International Community Medical (QSICM) operates community healthcare service centers. The Clinic offers internal medicine, pediatrics, gynecology, stomatology, laboratory, ultrasonography, and electrocardiography services. QSICM serves patients in China.

Anxin Doctor

Series B in 2017
Anxin Doctor is a mobile maternal and pediatric health platform that connects patients with obstetrics, gynecology doctors and pediatrics doctors.

Bondent Technology

Series B in 2017
Provider of integrated oral medical solutions for oral health and dental industry. The company offers technical training, operation and management consulting services to their clients. The company also involves in the design, development, manufacturing, and sales of oral medical equipment, providing a full fledged ecosystem for the dental and oral health industry.

Diandoc

Seed Round in 2017
Diandoc is a surgical referral service platform.

dMed

Series A in 2016
dMed Company Limited, also known as, dMed Biopharmaceutical Co., Ltd. operates as clinical contract research organization providing services for development of medicines and medical devices. The company offer services, including consulting, clinical operations, biostatistics & programming, data management, pharmacovigilance, clinical science & medical affairs, quality assurance, and regulatory affairs & Strategy. It serves biopharmaceutical and medical device companies. dMed Company Limited was founded in 2016 and is based in Shanghai, China.

Bondent Technology

Series C in 2016
Provider of integrated oral medical solutions for oral health and dental industry. The company offers technical training, operation and management consulting services to their clients. The company also involves in the design, development, manufacturing, and sales of oral medical equipment, providing a full fledged ecosystem for the dental and oral health industry.

MedSci

Series A in 2015
MedSci provides strategies, solutions and services to pharmaceutical, biotech and medical device organization and the consumer healthcare industry

WeDoctor

Venture Round in 2014
WeDoctor Holdings (Zhejiang) Co., Ltd. is a prominent medical and health technology platform based in Hangzhou, China, founded in 2010. The company specializes in developing solutions that utilize medical cloud and artificial intelligence technologies for various stakeholders, including governments, hospitals, and primary medical institutions. WeDoctor offers a range of services through its WeDoctor Cloud platform, which facilitates online and offline medical services, general practice, specialty consultations, and appointment registrations. Additionally, the company provides managed health services through WeDoctor HMO, aiming to enhance the medical care experience for users. With a mission to improve access to healthcare and promote overall wellness, WeDoctor strives to empower individuals and families through innovative healthcare solutions that integrate both digital and traditional services.
Beijing Richen-Force Science & Technology Co., Ltd., founded in July 2002, specializes in the development, manufacture, and marketing of medical devices, particularly in the field of gastroenterology. The company offers a range of products, including 13C urea breath diagnosis systems and test kits, Mirocam capsules, heat probe treatment systems for gastric diseases, and HpSA immune cards. It has established R&D centers and production bases in Beijing, Guangzhou, and Taizhou, as well as subsidiaries in Italy and Brazil, and a research center in the USA. Richen-Force has achieved significant global reach, exporting its 13C-UBT products to over 60 countries and serving more than 6,000 customers. The 13C urea breath test, known for its non-invasive and painless nature, has become the preferred standard for H. Pylori diagnosis, holding a 70% market share in China and positioning the company as a leading competitor in the global market for this technology.

Sanyou Medical

Series A in 2014
Shanghai Sanyou Medical Co., Ltd. specializes in the research, development, manufacturing, and sale of orthopedic implants in China. The company offers a range of products under the Tytus and Sanyou brands, including spinal implants such as anterior cervical plates and thoracolumbar systems, as well as minimally invasive options. In addition to spinal products, Sanyou Medical produces trauma implants for various applications, including shoulder, elbow, hip, pelvis, knee, and wrist systems. Headquartered in the Medical Apparatus Garden of Zhangjiang Hi-Tech Park in Shanghai, the company emphasizes innovative therapies and has implemented a restructured management system to enhance its sustainability and value in the healthcare sector.
Goodwill Infotech provides clinical information.

Aeonmed Medical Treatment

Series A in 2010
Aeonmed Medical Treatment (至尊租车) is a manufacturer and supplier of operating theatre and ICU devices, and medical treatment system solutions. Since its foundation, Aeonmed has always been guided by the clinical demands, and dedicated to the study of clinical medical equipment and solutions. Now, Aeonmed business covers three major product portfolios, including anesthesia and operation support, emergency and critical care and medical engineering equipment, and five major medical system solutions including laminar flow monitoring, environment and equipment configuration, centralized gas supply, process quality control and information integration. Currently, Aeon has more than 600 authorized and declared patents, among which there are more than 400 patents for invention, maintaining an increase of over 100 patents each year.